TRAIL deficiency does not rescue impaired CD8+ T cell memory generated in the absence of CD4+ T cell help - PubMed (original) (raw)
TRAIL deficiency does not rescue impaired CD8+ T cell memory generated in the absence of CD4+ T cell help
Jilian A Sacks et al. J Immunol. 2008.
Abstract
Ag-specific CD8(+) T cells immunized in the absence of CD4(+) T cell help, so-called "unhelped" CD8(+) T cells, are defective in function and survival. We investigated the role of the proapoptotic molecule TRAIL in this defect. We first demonstrate that TRAIL does not contribute to the CD8(+) T cell response to Listeria monocytogenes strain expressing OVA (LmOVA) in the presence of CD4(+) T cells. Secondly, we generated mice doubly deficient in CD4(+) T cells and TRAIL and analyzed their CD8(+) T cell response to LmOVA. Memory CD8(+) T cells in double-deficient mice waned over time and were not protective against rechallenge, similar to their TRAIL-sufficient unhelped counterparts. To avoid the effects of CD4(+) T cell deficiency during memory maintenance, and to address whether TRAIL plays a role in the early programming of the CD8(+) T cell response, we performed experiments using heterologous prime and early boost immunizations. We did not observe activation-induced cell death of unhelped CD8(+) T cells when mice were infected with followed vaccinia virus expressing OVA 9 days later by LmOVA infection. Furthermore, primary immunization of CD4(+) T cell-deficient mice with cell-associated Ag followed by LmOVA infection did not reveal a role for TRAIL-mediated activation-induced cell death. Overall, our results suggest that CD4(+) T cell help for the CD8(+) T cell response is not contingent on the silencing of TRAIL expression and prevention of TRAIL-mediated apoptosis.
Conflict of interest statement
Disclosures
The authors have no financial conflicts of interest.
Figures
FIGURE 1
TRAIL deficiency does not affect the kinetics or magnitude of the primary and secondary CD8+T cell responses to LmOVA. WT and TRAIL−/− (TR−/−) mice were infected with 2000 CFU LmOVA. A, The bacterial burden in the spleen was determined at the indicated time points postinfection. Each point is an individual mouse. The limit of detection was 100 CFU as indicated by the dotted line. B, At the indicated time points after infection, the OVA-specific response in the blood (day 7) and spleen (day 53) was quantified by tetramer staining and ICS following 4 h in vitro peptide stimulation (OVAp). FACS plots are gated on CD8+ T cells with at least two mice per genotype. The frequencies of cytokine producers indicated at the day 53 time point are the percentages of cells in each gate minus the background of the no peptide control (No pep). C, Each point indicates the average percentage of IFN-γ+CD8+ T cells ± SEM in the blood or spleen at the indicated time points postinfection. Data are representative of at least 2–3 mice per time point. D, Fifty-seven days after primary infection, WT and TR−/− mice were infected with 5 × 105 CFU LmOVA. Three days after infection the bacterial burden in the spleen and the OVA-specific response in the spleen and liver were quantified. A control mouse that had not been immunized before was infected with the same high dose (Naive). The FACS plots are gated on CD8+ T cells and are representative of 2–3 mice per genotype.
FIGURE 2
Despite TRAIL deficiency, CD8+ memory T cell numbers and function decline in the absence of CD4+ T cells. WT, MHC class II−/− (MHCII−/−), and double knockout TR−/− × MHCII−/− (Dbl KO) mice were infected with 2000 CFU LmOVA. A, Seven days postinfection the level of OVA-specific cells in the blood was determined by tetramer staining and ICS. All FACS plots are gated on CD8+ T cells. Data are representative of at least 3 mice per genotype. B, Expression of IL-7R_α_ by tetramer-positive cells was determined at day 7. Histograms are gated on KbOVA+CD8+ T cells. C, Sixty-seven days postinfection, OVA-specific memory levels were assessed in the spleen. The FACS plots are gated on CD8+ T cells. Blood from an unimmunized WT mouse was used as a tetramer staining control. D, Cytokine expression by the memory cells. The FACS plots are gated on CD8+ T cells, and the lower histograms depict the percentage of IL-2+ cells of IFN-_γ_-producing CD8+ T cells, with the gray lines indicating expression by CD8+ T cells from the same animals that were not restimulated with peptide (No pep). Data are representative of 2–3 mice per genotype.
FIGURE 3
TRAIL deficiency does not restore impaired recall response of CD8+ T cells observed in the absence of CD4+ T cell help. Seventy-one days following primary infection with LmOVA WT, MHCII−/− and Dbl KO mice were infected with 2 × 105 CFU LmOVA. The bacterial burden and OVA-specific response were assessed 3 days later. Mice of each genotype that had not been immunized before were infected as controls (Naive). A, The OVA-specific recall response in the spleen was determined by tetramer staining and ICS. All FACS plots are gated on CD8+ T cells. B, The absolute number of KbOVA+CD8+ T cells was quantified in the spleen of mice that were not rechallenged (day 67 post primary infection) and in other mice that were rechallenged (3 days postrecall at 71 days after primary infection). The numbers on the graph indicate the fold expansion. C, Three days after rechallenge, the bacterial burden in the spleen was determined. The dotted line indicates the limit of detection. Data depict the average CFU/spleen of 2–3 mice per group ± SEM.
FIGURE 4
Early secondary challenge reveals no role for CD4+ T cell help or TRAIL. Mice of the indicated genotypes were infected with 2 × 106 PFU Vacc-OVA i.p. A, The OVA-specific response was analyzed 7 days later by tetramer staining in the blood. FACS plots are gated on CD8+ T cells and show the average ± SEM of 2– 4 mice per group. An uninfected mouse is shown as a tetramer staining control (No Vacc-OVA). B, Nine days after primary infection, mice were infected with 2 × 104 CFU LmOVA i.v. The OVA-specific response was analyzed 5 days later in the spleen (day 14) by tetramer staining. FACS plots are gated on CD8+ T cells and are representative of 2– 4 mice per genotype. A WT mouse infected only with LmOVA 5 days before is shown (No Vacc-OVA).
FIGURE 5
Absence of TRAIL does not rescue cells primed by a helper-dependent immunogen. Mice of the indicated genotypes were immunized with 107 irradiated Act-mOVA splenocytes s.c. and 10 days later were infected (B) or not (A) with 4 × 104 CFU LmOVA i.v. The OVA-specific response was analyzed 4 days later (day 14 after cellular immunization) by ICS in the spleen. FACS plots are gated on CD8+ T cells. Numbers indicate the frequency of cytokine-producing CD8+ T cells in each gate. C, The absolute number of IFN-_γ_-producing cells was quantified in the spleen. Frequencies were determined by subtracting the staining from the no peptide control. Naive WT mice infected with LmOVA 4 days before are shown as a control. Data represent the average of at least two mice per genotype ± SEM.
Similar articles
- IL-15 as a mediator of CD4+ help for CD8+ T cell longevity and avoidance of TRAIL-mediated apoptosis.
Oh S, Perera LP, Terabe M, Ni L, Waldmann TA, Berzofsky JA. Oh S, et al. Proc Natl Acad Sci U S A. 2008 Apr 1;105(13):5201-6. doi: 10.1073/pnas.0801003105. Epub 2008 Mar 24. Proc Natl Acad Sci U S A. 2008. PMID: 18362335 Free PMC article. - TRAIL deficiency delays, but does not prevent, erosion in the quality of "helpless" memory CD8 T cells.
Badovinac VP, Messingham KA, Griffith TS, Harty JT. Badovinac VP, et al. J Immunol. 2006 Jul 15;177(2):999-1006. doi: 10.4049/jimmunol.177.2.999. J Immunol. 2006. PMID: 16818756 - Nab2 regulates secondary CD8+ T-cell responses through control of TRAIL expression.
Wolkers MC, Gerlach C, Arens R, Janssen EM, Fitzgerald P, Schumacher TN, Medema JP, Green DR, Schoenberger SP. Wolkers MC, et al. Blood. 2012 Jan 19;119(3):798-804. doi: 10.1182/blood-2011-08-373910. Epub 2011 Nov 29. Blood. 2012. PMID: 22128144 Free PMC article. - Differential requirements of CD4(+) T-cell signals for effector cytotoxic T-lymphocyte (CTL) priming and functional memory CTL development at higher CD8(+) T-cell precursor frequency.
Umeshappa CS, Nanjundappa RH, Xie Y, Freywald A, Xu Q, Xiang J. Umeshappa CS, et al. Immunology. 2013 Apr;138(4):298-306. doi: 10.1111/imm.12033. Immunology. 2013. PMID: 23113741 Free PMC article. - CD8 T cell memory development: CD4 T cell help is appreciated.
Khanolkar A, Badovinac VP, Harty JT. Khanolkar A, et al. Immunol Res. 2007;39(1-3):94-104. doi: 10.1007/s12026-007-0081-4. Immunol Res. 2007. PMID: 17917058 Review.
Cited by
- HLA-Class II Artificial Antigen Presenting Cells in CD4+ T Cell-Based Immunotherapy.
Couture A, Garnier A, Docagne F, Boyer O, Vivien D, Le-Mauff B, Latouche JB, Toutirais O. Couture A, et al. Front Immunol. 2019 May 17;10:1081. doi: 10.3389/fimmu.2019.01081. eCollection 2019. Front Immunol. 2019. PMID: 31156634 Free PMC article. Review. - Recall responses by helpless memory CD8+ T cells are restricted by the up-regulation of PD-1.
Fuse S, Tsai CY, Molloy MJ, Allie SR, Zhang W, Yagita H, Usherwood EJ. Fuse S, et al. J Immunol. 2009 Apr 1;182(7):4244-54. doi: 10.4049/jimmunol.0802041. J Immunol. 2009. PMID: 19299723 Free PMC article. - Plasticity in programming of effector and memory CD8 T-cell formation.
Arens R, Schoenberger SP. Arens R, et al. Immunol Rev. 2010 May;235(1):190-205. doi: 10.1111/j.0105-2896.2010.00899.x. Immunol Rev. 2010. PMID: 20536564 Free PMC article. Review. - Physiological numbers of CD4+ T cells generate weak recall responses following influenza virus challenge.
Thomas PG, Brown SA, Morris MY, Yue W, So J, Reynolds C, Webby RJ, Doherty PC. Thomas PG, et al. J Immunol. 2010 Feb 15;184(4):1721-7. doi: 10.4049/jimmunol.0901427. Epub 2010 Jan 8. J Immunol. 2010. PMID: 20061406 Free PMC article. - TNF-Related Apoptosis-Inducing Ligand: Non-Apoptotic Signalling.
Guerrache A, Micheau O. Guerrache A, et al. Cells. 2024 Mar 16;13(6):521. doi: 10.3390/cells13060521. Cells. 2024. PMID: 38534365 Free PMC article. Review.
References
- Prlic M, Williams MA, Bevan MJ. Requirements for CD8 T-cell priming, memory generation, and maintenance. Curr Opin Immunol. 2007;19:315–319. - PubMed
- Badovinac VP, Messingham KA, Griffith TS, Harty JT. TRAIL deficiency delays, but does not prevent, erosion in the quality of “helpless” memory CD8 T cells. J Immunol. 2006;177:999–1006. - PubMed
- Williams MA, Bevan MJ. Effector and memory CTL differentiation. Annu Rev Immunol. 2007;25:171–192. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- HHMI/Howard Hughes Medical Institute/United States
- R01 AI019335/AI/NIAID NIH HHS/United States
- R01 AI019335-19/AI/NIAID NIH HHS/United States
- AI 19335/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials